In Cancer Res. (2018) [20]REDD1 is surely an oncogene. BUC Antagonizing REDD1 may very well
In Cancer Res. (2018) REDD1 is surely an oncogene. BUC Antagonizing REDD1 may very well be a potential therapeutic system to sensitize BUC cells to paclitaxelwhereas cytoplasmic REDD1 expression was…